Niagara Health System-Saint Catharines General

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Kidney cancer1 trial
• Lung cancer1 trial
• Obesity1 trial
• Prostate cancer1 trial

Phase

• Phase 34 trials
• Phase 2/32 trials

Status

• Active, not recruiting4 trials
• Recruiting2 trials

Lead sponsor

• National Cancer Institute (NCI)2 trials
• NRG Oncology2 trials
• Alliance for Clinical Trials in Oncology1 trial
• Canadian Cancer Trials Group1 trial

Running trials

• Recruiting

  Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  NCT06592924· Phase 3· Canadian Cancer Trials Group· Source

  Contact: David W. Wasserman (principal investigator)

• Recruiting

  Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  NCT05174169· Phase 2/3· NRG Oncology· Source

  Contact: Radhika Yelamanchili (principal investigator)

• Active, not recruiting

  Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

  NCT04068103· Phase 2/3· NRG Oncology· Source

• Active, not recruiting

  Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

  NCT03793179· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

  NCT03055013· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· Phase 3· Alliance for Clinical Trials in Oncology· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Prostate cancer1 recruiting